Clinical trials: Therapeutic Abortion
Contraception, Abortion, Therapeutic
Nexplanon Application Post-Abortion (NAPA)
Women who receive Nexplanon immediately post abortion will be significantly more likely to be using the device 6 months after the procedure than those assigned to receive the device 2-4 weeks after the procedure.
- Trial name
- NAPA (NCT02037919)
- Testing
- Immediate Nexplanon Insertion, Post-op Nexplanon Insertion
- Where
- 2 sites in United States
- Volunteers
- 148 people
- Sponsor
- Family Planning Associates Medical Group, LTD
Therapeutic Abortion
Same-day Dilapan-S With Adjunctive Misoprostol
Cervical preparation before second trimester dilation and evacuation (D\&E) reduces risks and complications. Osmotic cervical dilators as well as prostaglandin analogues have been studied for cervical preparation.
- Trial name
- DAM (NCT01818414)
- Testing
- Misoprostol, Folic Acid
- Where
- 2 sites in United States
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh